Moser M
Yale University School of Medicine, New Haven, Connecticut.
Eur Heart J. 1992 Dec;13 Suppl G:72-80. doi: 10.1093/eurheartj/13.suppl_g.72.
Thiazide diuretics are efficacious, either as monotherapy or in combination with other antihypertensive drugs. They reduce blood pressure in a high percentage of hypertensive patients with minimal subjective side effects. There is increasing evidence that the use of diuretics, singly or in combination, will reduce morbidity and mortality associated with essential hypertension in both young and elderly subjects. Although diuretics may induce some changes in the plasma lipid profile, serum uric acid concentration and glucose metabolism, there is little evidence that these changes are of clinical significance. The increase in serum cholesterol concentration has rarely persisted in any trial beyond the first year of treatment. The incidence of diabetes mellitus in diuretic treated subjects is only about 1%, even when large doses are used. Gout may be precipitated in susceptible subjects, but is uncommon. For these reasons, diuretics should remain a preferred first-step drug of choice in the management of hypertension.
噻嗪类利尿剂无论是单独使用还是与其他抗高血压药物联合使用都很有效。它们能使高比例的高血压患者血压降低,且主观副作用最小。越来越多的证据表明,单独或联合使用利尿剂将降低年轻和老年原发性高血压患者的发病率和死亡率。尽管利尿剂可能会引起血浆脂质谱、血清尿酸浓度和葡萄糖代谢的一些变化,但几乎没有证据表明这些变化具有临床意义。在任何试验中,血清胆固醇浓度的升高在治疗的第一年之后很少持续存在。即使使用大剂量利尿剂,接受利尿剂治疗的受试者中糖尿病的发病率也仅约为1%。痛风可能在易感人群中诱发,但并不常见。出于这些原因,利尿剂应仍然是高血压治疗中首选的一线药物。